The North America Phenylketonuria Treatment Market is driven by the availability of dietary therapies, enzyme replacement options, supplements, and specialized clinical services for patients with phenylketonuria. The United States remains a major regional contributor, while Canada is also strengthening screening and long-term disease management programs. The Phenylketonuria Treatment Market was...